Resources
The National Pharmaceutical Council (NPC) is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation.
Filter by:
Topic
Topic
- Accountable Care Organizations
- Alternative Payment Models
- Biopharmaceutical Innovation
- Bundled Payments
- Clinical Pathways
- Decision Frameworks
- Elements of Value
- Evidence for Decision Making
- Formulary/Benefit Design
- Formulary Development
- Good Practices for Evidence
- Health Care Quality Measures
- (-) Health Spending
- Health Spend Management
- High-Deductible Health Plans
- (-) Impact on Outcome & Spending
- Individual Treatment Effects & Personalized Access
- IRA Implementation
- Low-Value Care
- Pandemic Response
- (-) Patient Cost Sharing
- Paying for Cures
- Policy & Regulatory Barriers
- Real-World Data
- Real-World Evidence
- Regulatory Barriers & Challenges
- Understanding Health Spending
- Utilization Management & Step Therapy
- Value-Based Contracts
- Value-Based Insurance Design
- (-) Value Assessment
- Value Assessment Frameworks
- Value Assessment Methods
Resource Type
Audience
Audience
Display Only
Showing 199 Results
NPC’s Dubois Named to Health Affairs Council on Health Care Spending and Value
Leading health policy journal Health Affairs announced the members of its Council on Health Care Spending and Value, a group of diverse health care thought leaders focused on examining the different…
Going Below the Surface E-Newsletter: September 2018
In this issue, we explore incentives in hospital and physician care.
National Pharmaceutical Council to CVS: Join Us in a Broader Dialogue to Address Health Care Spending
The viewpoints published on the Health Affairs Blog bring an important question to mind: will CVS join the National Pharmaceutical Council and key stakeholders from across the health sector in our…
Going Below the Surface E-newsletter: August 2018
In this issue, we share a video with experts on the importance of understanding health care spending, why patient engagement matters, and more on value-based care.
Going Below the Surface: A Video on Why We Need to Have a Health Spending Dialogue
Watch health care experts explain why it's important to find tangible solutions to inefficiencies in the American health care system.
Going Below the Surface E-newsletter: July 2018
In this issue, we explore spending on end of life care and Medicare and Medicaid spending.
Controlling Health Care Costs Means Confronting Misconceptions
The only way that we can begin to reduce overspending on health care is if we base decisions on what the evidence indicates.
NPC in Specialty Pharmacy Times: Going Below the Headlines on Health Spending in Four Steps
In his latest commentary for Specialty Pharmacy Times, NPC President Dan Leonard offers four suggestions to reconsider how we assess, analyze and apply the evidence and data around health spending to…
National Pharmaceutical Council and Anthem Support Health Affairs in Launching New Council on Health Care Spending and Value
NPC launched a broader stakeholder initiative funding research and supporting a series of papers and blog posts in Health Affairs last December. It is in service of this broader mission that NPC,…
Are Payers Ready to Address the Financial Challenges Associated with Gene Therapy?
An article published on the Health Affairs Blog explores the tensions with paying for gene therapies via online market research with payers and highlights a few proposals to address these concerns.
The Effect of Medical Technology Innovations on Patient Outcomes, 1990-2015: Results of a Physician Survey
A survey published in the Journal of Managed Care & Specialty Pharmacy of U.S. physicians provides insight on their perceptions regarding which medical innovation has impacted outcomes the most…
Survey Data Shows Physicians See Pharmaceuticals as Leading Contributor to Improved Health Outcomes
Research by RTI Health Solutions and the National Pharmaceutical Council shows the value of biopharmaceutical and pharmaceutical innovations to improving patient health.